Tumor Ablation Market Research Report – Global Forecast till 2027

Tumor Ablation Market: Information by Technology (Radiofrequency, Microwave), Treatment (Surgical, Percutaneous), Application (Liver cancer, Lung cancer), By End User (Hospital, Surgical and Ablation Centers) - Global Forecast Till 2027

ID: MRFR/MED/5673-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario: The Global Tumor Ablation Market accounts for USD 363.1 million in 2017 and expected to register healthy CAGR ~12.8% during the forecast period.


Tumor ablation is a minimally invasive image-guided technique used in treatment of the tumors in the liver, kidney, soft tissue and bone. It ensures high efficacy of tumor treatment with minimal side effects by using heat, chemicals and low temperature. The growing geriatric population and with-it increasing prevalence of cancer cases are responsible for driving the growth of the market. According to the Canadian Cancer Society, in 2017, an estimated 206,200 new cases of cancer and 80,800 deaths were occurred in Canada. Additionally, Office for National Statistics reported over 65.3% of total cancers were registered in adults aged 65 years in UK, 2016. The growing adoption for minimally invasive surgical procedures, high presence of surgical and ablation centers, and technological advancements are contributing to the rising demand for ablation technologies.


The increasing government restrictions, stringent regulatory authorities, and cost suppression measures adopted by different governments are hampering the growth of the market during the assessment period.


Segmentation: The Global Tumor Ablation Market has been segmented on the basis of technology, treatment, application, and end-user.


On the basis of technology, the market has been classified into radiofrequency, microwave, irreversible electroporation, cryoablation and others.


Tumor Ablation Market on the basis of treatment has been segmented into surgical, percutaneous and laparoscopic.


The application segment is divided into liver cancer, lung cancer, breast cancer, bone cancer, prostate cancer and others.


The market, by end-user, has been segmented into hospitals, surgical and ablation centers, and research institute.


The Tumor Ablation Markett has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Tumor Ablation Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European tumor ablation market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The Tumor Ablation Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Tumor Ablation Market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Tumor Ablation Market Share, by Region, 2017 (%)


Source: MRFR Analysis


The Americas are expected to dominate the global tumor ablation market owing to the increasing pool of cancer patients associated with rising elderly population, favorable reimbursement policies, and adoption of advanced healthcare facilities coupled with increased awareness about cancer detection and treatment in general population. According to the National Cancer Institute, in 2016, in United states 15.5 million new cases of cancer were registered and approximately USD 147.3 billion were spend for cancer care.


The European market is expected to be the second-largest tumor ablation market. The market growth in this region can be attributed to the increasing prevalence of cancer along with rising healthcare expenditure is expected to drive the growth of the market. According to European commission, in 2016 European nations invested 16.2% of its total expenditure on healthcare.


Asia-Pacific is expected to be the fastest-growing tumor ablation market during the forecast period owing to the increasing geriatric population in the region, continuously increasing investment in healthcare, and high demand of advanced technologies in healthcare. According to the Economic and Social Commission for Asia and the Pacific (ESCAP), 12.4% of the total Asian population is  60 or above 60-year-old and by 2050 one third of the population will cross 60 year.


The market in the Middle East & Africa is expected to account for the smallest share of the global tumor ablation market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players: Some of the key players in the global tumor ablation market are SonaCare Medical, Medtronic Plc., EDAP TMS, AngioDynamics Inc., Healthtronics Inc., Neuwave Medical, Inc., Boston Scientific Corporation, Biotronik, Galil Medical, Inc, Misonix Inc., and Covidien PLC


Global Tumor Ablation Market, by Technology:



  • Radiofrequency

  • Microwave

  • Irreversible Electroporation

  • Cryoablation

  • Others


Global Tumor Ablation Market, by Treatment:



  • Surgical

  • Percutaneous

  • Laparoscopic


Global Tumor Ablation Market, by Application:



  • Liver cancer

  • Lung cancer

  • Breast cancer

  • Bone cancer

  • Prostate cancer

  • Others


Global Tumor Ablation Market, by End-User:



  • Hospitals

  • Surgical and ablation Centers

  • Research Institute


Global Tumor Ablation Market, by Region:



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Company Profiles:    



  • SonaCare Medical

  • Medtronic Plc.

  • EDAP TMS,

  • AngioDynamics Inc.

  • Healthtronics Inc.

  • Neuwave Medical Inc.

  • Boston Scientific Corporation

  • Biotronik

  • Galil Medical Inc.

  • Misonix Inc.

  • Covidien PLC


Intended Audience:



  • Ablation device manufacturing suppliers and companies

  • Healthcare providers

  • Research institutes and academic centers

  • Contract manufacturing organizations (CMOs)

  • Market research and consulting


 



Frequently Asked Questions (FAQ) :


The tumor ablation market had a valuation of USD 363.1 million in 2017.

The tumor ablation market had a predicted CAGR of 12.8% during the forecast period of 2018 to 2023.

The global tumor ablation market growth can be dampened by strict regulations and cost suppression measures.

The tumor ablation market has end users like a hospital, research institute, and surgical & ablation centers.

The Americas is leading the tumor ablation market.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Tumor Ablation Market, by Technology

6.1 Introduction

6.2 Radiofrequency

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Microwave

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Irreversible Electroporation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Cryoablation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Other Applications

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Tumor Ablation Market, byTreatment

7.1 Introduction

7.2 Surgical Ablation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Percutaneous Ablation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Laparoscopic Ablation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027


Chapter 8. Global Tumor Ablation Market, by Application

8.1 Introduction

8.2 Liver cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Lung cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Breast cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Bone cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Prostate cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027


Chapter 9. Global Tumor ablationMarket, by End-User

9.1 Introduction

9.2 Hospital

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Surgical and Ablation Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Research Institute

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Tumor Ablation Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 SonaCare Medical

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Medtronic Plc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 EDAP TMS

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 AngioDynamics , Inc.

12.4.1 Company Overview

12.4.2 Technologys/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Healthtronics, Inc.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Neuwave Medical, Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Boston Scientific Corporation

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis


12.8 Biotronik

12.8.1 Overview

12.8.2 Treatment Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Galil Medical Inc.

12.9.1 Overview

12.9.2 Treatment Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Misonix Inc.

12.10.1 Overview

12.10.2 Treatment Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Covidien PLC

12.11.1 Overview

12.11.2 Treatment Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Tumor Ablation Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Tumor Ablation Market Synopsis, 2020-2027

Table 2 Global Tumor Ablation Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Tumor Ablation Market, by Region, 2020-2027 (USD Million)

Table 4 Global Tumor ablationMarket, by Technology, 2020-2027 (USD Million)

Table 5 Global Tumor ablationMarket, by Treatment, 2020-2027 (USD Million)

Table 6 Global Tumor ablationMarket, by, Application 2020-2027 (USD Million)

Table 7 Global Tumor ablationMarket, by End-User, 2020-2027 (USD Million)

Table 8 North America: Tumor Ablation Market, by Technology, 2020-2027 (USD

Million)

Table 9 North America: Tumor Ablation Market, by Treatment, 2020-2027 (USD

Million)

Table 10 North America: Tumor AblationMarket, by Application Treatment , 2020-2027 (USD

Million)

Table 11 North America: Tumor Ablation Market, by End-User, 2020-2027 (USD

Million)

Table 12 US: Tumor Ablation Market, by Technology, 2020-2027 (USD Million)

Table 13 US: Tumor Ablation Market, by Treatment, 2020-2027 (USD Million)

Table 14 US: Tumor Ablation Market, by Application , 2020-2027 (USD Million)

Table 15 US: Tumor Ablation Market, by End-User, 2020-2027 (USD Million)

Table 16 Canada: Tumor Ablation Market,by Technology, 2020-2027 (USD Million)

Table 17 Canada: Tumor Ablation Market, by Treatment, 2020-2027 (USD Million)

Table 18 Canada: Tumor Ablation Market, by Application, 2020-2027 (USD

Million)

Table 19 Canada: Tumor Ablation Market, by End-User, 2020-2027 (USD

Million)

Table 20 South America: Tumor Ablation Market, by Technology, 2020-2027 (USD

Million)

Table 21 South America: Tumor Ablation Market, by Treatment, 2020-2027 (USD

Million)

Table 22 South America: Tumor Ablation Market, by Application, 2020-2027 (USD

Million)

Table 23 South America: Tumor Ablation Market, by End-User, 2020-2027 (USD

Million)

Table 24 Europe: Tumor Ablation Market, by Technology, 2020-2027 (USD Million)

Table 25 Europe: Tumor Ablation Market, by Treatment, 2020-2027 (USD Million)

Table 26 Europe: Tumor Ablation Market, by Application, 2020-2027 (USD Million)

Table 27 Europe: Tumor Ablation Market, by End-User, 2020-2027 (USD Million)

Table 28 Western Europe: Tumor Ablation Market, by Technology, 2020-2027 (USD

Million)

Table 29 Western Europe: Tumor Ablation Market, by Treatment, 2020-2027 (USD

Million)

Table 30 Western Europe: Tumor Ablation Market, by Application, 2020-2027

(USD Million)

Table 31 Western Europe: Tumor Ablation Market, by End-User, 2020-2027

(USD Million)

Table 32 Eastern Europe: Tumor Ablation Market, by Technology, 2020-2027 (USD

Million)

Table 33 Eastern Europe: Tumor Ablation Market, by Treatment, 2020-2027 (USD

Million)

Table 34 Eastern Europe: Tumor Ablation Market, by Application, 2020-2027

(USD Million)

Table 35 Eastern Europe: Tumor Ablation Market, by End-User, 2020-2027

(USD Million)

Table 36 Asia-Pacific: Tumor Ablation Market, by Technology, 2020-2027 (USD

Million)

Table 37 Asia-Pacific: Tumor ablationMarket, by Treatment, 2020-2027 (USD

Million)

Table 38 Asia-Pacific: Tumor Ablation Market, by Application, 2020-2027 (USD

Million)

Table 39 Asia-Pacific: Tumor Ablation Market, by End-User, 2020-2027 (USD

Million)

Table 40 Middle East & Africa: Tumor Ablation Market, by Technology, 2020-2027

(USD Million)

Table 41 Middle East & Africa: Tumor Ablation Market, by Treatment, 2020-2027

(USD Million)

Table 42 Middle East & Africa: Tumor Ablation Market, by Application, 2020-2027

(USD Million)

Table 43 Middle East & Africa: Tumor Ablation Market, by End-User, 2020-2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Tumor Ablation Market

Figure 3 Segmentation Market Dynamics for Global Tumor Ablation Market

Figure 4 Global Tumor Ablation Market Share, by Technology, 2020

Figure 5 Global Tumor Ablation Market Share, by Treatement, 2020

Figure 6 Global Tumor Ablation Market Share, by Application, 2020

Figure 7 Global Tumor Ablation Market Share, by End-User, 2020

Figure 8 Global Tumor Ablation Market Share, by Region, 2020

Figure 9 North America: Tumor Ablation Market Share, by Country, 2020

Figure 10 Europe: Tumor Ablation Market Share, by Country, 2020

Figure 11 Asia-Pacific: Tumor Ablation Market Share, by Country, 2020

Figure 12 Middle East & Africa: Tumor Ablation Market Share, by Country, 2020

Figure 13 Global Tumor Ablation Market: Company Share Analysis, 2020 (%)

Figure 14 SonaCare Medical: Key Financials

Figure 15 SonaCare Medical: Segmental Revenue

Figure 16 SonaCare Medical: Geographical Revenue

Figure 17 Medtronic Plc.: Key Financials

Figure 18 Medtronic Plc.: Segmental Revenue

Figure 19 Medtronic Plc.: Geographical Revenue

Figure 20 EDAP TMS: Key Financials

Figure 21 EDAP TMS: Segmental Revenue

Figure 22 EDAP TMS: Geographical Revenue

Figure 23 AngioDynamics,Inc.: Key Financials

Figure 24 AngioDynamics,Inc.: Segmental Revenue

Figure 25 AngioDynamics,Inc.: Geographical Revenue

Figure 26 Healthtronics,Inc.: Key Financials

Figure 27 Healthtronics,Inc.: Segmental Revenue

Figure 28 Healthtronics,Inc.:Geographical Revenue

Figure 29 Neuwave Medical, Inc.: Key Financials

Figure 30 Neuwave Medical, Inc.: Segmental Revenue

Figure 31 Neuwave Medical, Inc.: Geographical Revenue

Figure 32 Boston Scientific Corporation: Key Financials

Figure 33 Boston Scientific Corporation: Segmental Revenue

Figure 34 Boston Scientific Corporation: Geographical Revenue

Figure 35 Biotronik: Key Financials

Figure 36 Biotronik: Segmental Revenue

Figure 37 Biotronik: Geographical Revenue

Figure 38 Galil Medical, Inc: Key Financials

Figure 39 Galil Medical, Inc: Segmental Revenue

Figure 40 Galil Medical, Inc: Geographical Revenue

Figure 41 Misonix Inc: Key Financials

Figure 42 Misonix Inc: Segmental Revenue

Figure 43 Misonix Inc: Geographical Revenue

Figure 44 Covidien PLC: Key Financials

Figure 45 Covidien PLC: Segmental Revenue

Figure 46 Covidien PLC: Geographical Revenue